NASDAQ:ALPN

Alpine Immune Sciences, Inc Earning Date

USA |NASDAQ |USD

ALPN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $0.00 $-0.46 $-0.28
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $21.19M $7.19M $1.91M

Alpine Immune Sciences, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

ALPN Earnings Date & History Chart

ALPN Earnings & Revenue Forecast

ALPN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.33 $-0.53 $-0.08
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.19 $-1.96 $0.06
Dec 2022 4 $-1.34 $-2.24 $0.73

ALPN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.38 $-0.41 $-0.35
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.34 $-1.29 $-1.38
Dec 2022 0 / 0 $-1.40 $-1.35 $-1.11

ALPN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $11.69M $5.50M $21.75M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $43.27M $21.30M $75.40M
Dec 2022 4 $55.62M $29.00M $96.50M

ALPN Earnings Date & Revenue History

ALPN Earnings History

|
Show More
Show More

ALPN Revenue History

|
Show More
Show More

Alpine Immune Sciences, Inc Next Earnings Date & Report

ALPN Next Earnings Date & Report Preview: Sep 2021 (FQ)

ALPN's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Alpine Immune Sciences, Inc's next quarterly earnings is $0.00, with a low EPS estimation of $-0.52, and a high estimation of $1.13.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.09, the last 2 month trend is $0.05, and the 3 month trend is $-0.19.

Based on 6 analysts, the average revenue estimation is $21.19M, with a low revenue estimation of $5.40M, and a high estimation of $55.00M.

Alpine Immune Sciences, Inc Previous Earnings Dates & Reports

ALPN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Alpine Immune Sciences, Inc's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

ALPN's earnings per share (EPS) was $-0.46, missing the consensus analysts forecast of $-0.34 by -33.99%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 2.22%, and higher than the same period a year before (Jun 2020) by -13.21%.

Revenues were $7.19M, better than the forecast of $7.19M by 0.00%, up by 124.50% from the previous quarter , and up by 945.49% from the same period last year.

The company reported a net income of $-11.03M.

Free cash flow for the quarter was $-14.71M , compared to $-16.01M last quarter and $54.32M a year before.

ALPN ended the quarter with $22.40M in total debt, a decrease of -0.40% compared to the previous quarter, and an increase of 124.20% compared to the same quarter a year before.

ALPN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Alpine Immune Sciences, Inc's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.

ALPN's earnings per share (EPS) was $-1.34, beating the consensus analysts forecast of $-1.40 by -4.29% , and higher than the previous year's EPS (Dec 2019) by -41.48%.

Revenues were $9.34M, better than the forecast of $6.28M by 48.65%, and up by 436.49% from previous year's revenue.

The company reported a net income of $-27.94M.

Alpine Immune Sciences, Inc reported a free cash flow of $29.28M for its fiscal year, compared to $-36.17M a year ago.

The company ended the fiscal year with $10.78M in total debt, an increase of 118.86% compared to the previous year.